Ergoteles LLC Natera, Inc. Transaction History

Ergoteles LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$36.93 - $56.68 $451,247 - $692,572	12,219 New	12,219 $535,000
Q2 2022 Aug 12, 2022	SELL	$28.13 - $44.54 $642,151 - $1.02 Million	-22,828 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$30.32 - $91.33 $285,220 - $859,141	9,407 Added 70.09%	22,828 $929,000
Q4 2021 Feb 14, 2022	BUY	$86.26 - $119.0 $236,352 - $326,060	2,740 Added 25.65%	13,421 $1.25 Million
Q3 2021 Nov 15, 2021	SELL	$100.17 - $126.36 $15.7 Million - $19.8 Million	-156,719 Reduced 93.62%	10,681 $1.19 Million
Q2 2021 Aug 12, 2021	BUY	$86.05 - $119.72 $13.3 Million - $18.5 Million	154,247 Added 1172.71%	167,400 $19 Million
Q1 2021 May 12, 2021	BUY	$91.47 - $124.36 $1.2 Million - $1.64 Million	13,153 New	13,153 $1.34 Million

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.